table of content
1 Study Coverage
1.1 Alpha-1 Antitrypsin Drugs Product Introduction
1.2 Global Alpha-1 Antitrypsin Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Alpha-1 Antitrypsin Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Alpha-1 Antitrypsin Drugs Sales in Volume for the Year 2017-2028
1.3 United States Alpha-1 Antitrypsin Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Alpha-1 Antitrypsin Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Alpha-1 Antitrypsin Drugs Sales in Volume for the Year 2017-2028
1.4 Alpha-1 Antitrypsin Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Alpha-1 Antitrypsin Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Alpha-1 Antitrypsin Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Alpha-1 Antitrypsin Drugs Market Dynamics
1.5.1 Alpha-1 Antitrypsin Drugs Industry Trends
1.5.2 Alpha-1 Antitrypsin Drugs Market Drivers
1.5.3 Alpha-1 Antitrypsin Drugs Market Challenges
1.5.4 Alpha-1 Antitrypsin Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Alpha-1 Antitrypsin Drugs Market Segment by Type
2.1.1 Parenteral
2.1.2 Inhalation
2.2 Global Alpha-1 Antitrypsin Drugs Market Size by Type
2.2.1 Global Alpha-1 Antitrypsin Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Alpha-1 Antitrypsin Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Alpha-1 Antitrypsin Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Alpha-1 Antitrypsin Drugs Market Size by Type
2.3.1 United States Alpha-1 Antitrypsin Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Alpha-1 Antitrypsin Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Alpha-1 Antitrypsin Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Alpha-1 Antitrypsin Drugs Market Segment by Application
3.1.1 Drugstore
3.1.2 Hospital
3.1.3 Others
3.2 Global Alpha-1 Antitrypsin Drugs Market Size by Application
3.2.1 Global Alpha-1 Antitrypsin Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Alpha-1 Antitrypsin Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Alpha-1 Antitrypsin Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Alpha-1 Antitrypsin Drugs Market Size by Application
3.3.1 United States Alpha-1 Antitrypsin Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Alpha-1 Antitrypsin Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Alpha-1 Antitrypsin Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Alpha-1 Antitrypsin Drugs Competitor Landscape by Company
4.1 Global Alpha-1 Antitrypsin Drugs Market Size by Company
4.1.1 Top Global Alpha-1 Antitrypsin Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Alpha-1 Antitrypsin Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Alpha-1 Antitrypsin Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Alpha-1 Antitrypsin Drugs Price by Manufacturer (2017-2022)
4.2 Global Alpha-1 Antitrypsin Drugs Concentration Ratio (CR)
4.2.1 Alpha-1 Antitrypsin Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Alpha-1 Antitrypsin Drugs in 2021
4.2.3 Global Alpha-1 Antitrypsin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Alpha-1 Antitrypsin Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Alpha-1 Antitrypsin Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Alpha-1 Antitrypsin Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Alpha-1 Antitrypsin Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Alpha-1 Antitrypsin Drugs Market Size by Company
4.5.1 Top Alpha-1 Antitrypsin Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Alpha-1 Antitrypsin Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Alpha-1 Antitrypsin Drugs Sales by Players (2020, 2021 & 2022)
5 Global Alpha-1 Antitrypsin Drugs Market Size by Region
5.1 Global Alpha-1 Antitrypsin Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Alpha-1 Antitrypsin Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Alpha-1 Antitrypsin Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Alpha-1 Antitrypsin Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Alpha-1 Antitrypsin Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Alpha-1 Antitrypsin Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Alpha-1 Antitrypsin Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Alpha-1 Antitrypsin Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Alpha-1 Antitrypsin Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Alpha-1 Antitrypsin Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Alpha-1 Antitrypsin Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Alpha-1 Antitrypsin Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Alpha-1 Antitrypsin Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Baxter
7.1.1 Baxter Corporation Information
7.1.2 Baxter Description and Business Overview
7.1.3 Baxter Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Baxter Alpha-1 Antitrypsin Drugs Products Offered
7.1.5 Baxter Recent Development
7.2 CSL Behring
7.2.1 CSL Behring Corporation Information
7.2.2 CSL Behring Description and Business Overview
7.2.3 CSL Behring Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 CSL Behring Alpha-1 Antitrypsin Drugs Products Offered
7.2.5 CSL Behring Recent Development
7.3 Grifols
7.3.1 Grifols Corporation Information
7.3.2 Grifols Description and Business Overview
7.3.3 Grifols Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Grifols Alpha-1 Antitrypsin Drugs Products Offered
7.3.5 Grifols Recent Development
7.4 Kamada
7.4.1 Kamada Corporation Information
7.4.2 Kamada Description and Business Overview
7.4.3 Kamada Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Kamada Alpha-1 Antitrypsin Drugs Products Offered
7.4.5 Kamada Recent Development
7.5 Abeona Therapeutics
7.5.1 Abeona Therapeutics Corporation Information
7.5.2 Abeona Therapeutics Description and Business Overview
7.5.3 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Abeona Therapeutics Alpha-1 Antitrypsin Drugs Products Offered
7.5.5 Abeona Therapeutics Recent Development
7.6 Alnylam Pharmaceuticals
7.6.1 Alnylam Pharmaceuticals Corporation Information
7.6.2 Alnylam Pharmaceuticals Description and Business Overview
7.6.3 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Alnylam Pharmaceuticals Alpha-1 Antitrypsin Drugs Products Offered
7.6.5 Alnylam Pharmaceuticals Recent Development
7.7 Applied Genetic Technologies Corp
7.7.1 Applied Genetic Technologies Corp Corporation Information
7.7.2 Applied Genetic Technologies Corp Description and Business Overview
7.7.3 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Applied Genetic Technologies Corp Alpha-1 Antitrypsin Drugs Products Offered
7.7.5 Applied Genetic Technologies Corp Recent Development
7.8 Arrowhead Research Corporation
7.8.1 Arrowhead Research Corporation Corporation Information
7.8.2 Arrowhead Research Corporation Description and Business Overview
7.8.3 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Arrowhead Research Corporation Alpha-1 Antitrypsin Drugs Products Offered
7.8.5 Arrowhead Research Corporation Recent Development
7.9 Baxalta
7.9.1 Baxalta Corporation Information
7.9.2 Baxalta Description and Business Overview
7.9.3 Baxalta Alpha-1 Antitrypsin Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Baxalta Alpha-1 Antitrypsin Drugs Products Offered
7.9.5 Baxalta Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Alpha-1 Antitrypsin Drugs Industry Chain Analysis
8.2 Alpha-1 Antitrypsin Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Alpha-1 Antitrypsin Drugs Distributors
8.3 Alpha-1 Antitrypsin Drugs Production Mode & Process
8.4 Alpha-1 Antitrypsin Drugs Sales and Marketing
8.4.1 Alpha-1 Antitrypsin Drugs Sales Channels
8.4.2 Alpha-1 Antitrypsin Drugs Distributors
8.5 Alpha-1 Antitrypsin Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
